CLOCK and cancer: The purpose of the current study was to examine whether circadian clock-modulating compounds can be used to alter the expression of genes relevant to cisplatin DNA damage responses and thus control the anti-proliferative effects of this common anti-cancer therapeutic drug in cultured cells in vitro.